Rephonic
Artwork for Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Continuous Glucose Monitoring
Diabetes
Insulin Pumps
Diabetes Management
Eversense 365
FDA Approval
Medicare Coverage
Diabetes Technology
Ascensia
Omnipod 5
Dexcom G7
Tidepool
Dexcom G6
Libre 3
Ilit Insulin Pump
SGLT2 Inhibitors
Catalyst Trial
Hypercortisolism
Dexcom Stelo
Heart Failure

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology. Please... more

PublishesWeeklyEpisodes182Founded4 years ago
Number of ListenersCategories
MedicineScienceHealth & Fitness

Listen to this Podcast

Artwork for Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Latest Episodes

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!

In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide a comprehensive update on the rapidly evolving landscape of incretin-based thera... more

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!

In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide a detailed update on evolving incretin-based therapies, with a primary focus on a ... more

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!

In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, explore advances in implantable diabetes technologies, focusing on a novel implantable i... more

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!

In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, explore major updates in the evolving GLP-1 receptor agonist landscape, with a particula... more

Key Facts

Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

The Huddle: Conversations with the Diabetes Care Team
The Huddle: Conversations with the Diabetes Care TeamAssociation of Diabetes Care & Education Specialists
Diabetes Core Update
Diabetes Core UpdateAmerican Diabetes Association

Recent Guests

Bob Vigersky
Chief Medical Officer at Medtronic Diabetes
Medtronic
Episode: What's New at Medtronic Diabetes With Bob Vigersky, MD
Carol Levy
Professor in the Department of Medicine's Division of Endocrinology, Diabetes, and Bone Disease, and in the Department of Obstetrics, Gynecology, and Reproductive Science
Icahn School of Medicine at Mount Sinai
Episode: Upcoming Research on Type 1 Diabetes in Pregnancy with Carol Levy, MD
Rachael Sood
Nurse practitioner and CDCES, owner of the Diabetes Collective
The Diabetes Collective
Episode: The Diabetes Collective, with Rachael Sood, RN, MSN, APRN
Jay Shubrook
A primary care diabetologist with a background in family medicine.
American College of Diabetology
Episode: Addressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD
Conan Tu
An adult internist and primary care provider with a focus on diabetes care.
American College of Diabetology
Episode: Addressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD
John Buse
Professor at the University of North Carolina School of Medicine, diabetes clinician and clinical trialist.
University of North Carolina School of Medicine
Episode: CATALYST Trial, Mifepristone, and Hypercortisolism in T2D, with John Buse, MD, PhD
Kevin Sayer
CEO of Dexcom who has been pivotal in advancing diabetes monitoring technology.
Dexcom
Episode: Updates from Dexcom at ADA 2025, with Kevin Sayer
Melanie Davies
Professor of Diabetes Medicine from Leicester, UK, and PI on the REDEFINE trials.
University of Leicester
Episode: REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
Timothy Garvey
Endocrinologist with a focus on obesity treatment.
University of Alabama at Birmingham
Episode: REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD

Hosts

Diana Isaacs
Co-host with considerable expertise in diabetes management and technology applications in clinical settings.
Natalie Bellini
Co-host with a strong focus on patient-centric care and advancements in diabetes therapeutics.

Reviews

4.8 out of 5 stars from 23 ratings
  • Excellent podcast!

    Highly recommend for people living with diabetes! Thanks so much for the technology updates and diabetes management info you provide! :)

    Apple Podcasts
    5
    AEB9857
    United States2 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Many find the content to be engaging and relevant to their clinical practices, especially regarding the application of new therapeutics.
Listeners appreciate the podcast for its valuable updates and insights on diabetes management and technology.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
Q: What were the primary outcomes of the REDEFINE trials?
The primary outcomes were the mean percentage weight loss and the percentage of patients achieving greater than 5% weight loss.
REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
Q: Can you share a little about how THE REDEFINE 2 trial was designed?
REDEFINE 2 only had two arms, comparing CagriSema against placebo, focusing on patients with type 2 diabetes.
REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
Q: How were the side effects for the CagriSema group?
The side effects for the CagriSema group were similar to those for Semaglutide alone, with manageable gastrointestinal symptoms.
REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
Q: Can you tell us a little bit about the numbers and results in REDEFINE 1?
Patients in REDEFINE 1 achieved a 22.4% weight loss with CagriSema, significantly outperforming the other arms.
INHALE-3 Trial and Afrezza, With Roy Beck, MD, PhD
Q: Can you share a little bit about the Inhale-3 study and what the goals were?
The study aimed to assess the effectiveness of combining inhaled insulin with long-acting insulin for diabetes management across different user profiles.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

The content centers around recent advancements in diabetes management, healthcare technology, and treatment options for diabetes and metabolic diseases. Key discussions often feature updates on new pharmacological therapies, continuous glucose monitoring devices, and personalized patient care strategies, all aimed at enhancing professional knowledge for healthcare providers. Notably, episodes cover clinical trial outcomes, FDA approvals, and the integration of innovative technologies that enhance diabetes care, making the podcast a valuable resource for healthcare professionals seeking current, applicable information in the management of diabetes.

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. The Huddle: Conversations with the Diabetes Care Team
2. Diabetes Core Update
3. Diabetes Connections | Type 1 Diabetes
4. Diabetech - Diabetes Tech, Research, News
5. The Megyn Kelly Show

How many episodes of this podcast are there?

this podcast launched 4 years ago and published 182 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Bob Vigersky
2. Carol Levy
3. Rachael Sood
4. Jay Shubrook
5. Conan Tu
6. John Buse
7. Kevin Sayer
8. Melanie Davies

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days